Rovazolac Uses, Dosage, Side Effects and more
Rovazolac is under investigation in clinical trial NCT03175354 (A Study in Subjects With Moderate Atopic Dermatitis).
| Trade Name | Rovazolac |
| Generic | Rovazolac |
| Rovazolac Other Names | Rovazolac |
| Type | |
| Formula | C21H19F3N2O4S |
| Weight | Average: 452.45 Monoisotopic: 452.101762763 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
